NCT05234840 is a NA clinical trial of platelet rich plasma in PRP, sponsored by Queen Savang Vadhana Memorial Hospital, Thailand.

Who is sponsoring NCT05234840?

NCT05234840 is sponsored by Queen Savang Vadhana Memorial Hospital, Thailand.

What drugs are being tested in NCT05234840?

Interventions in NCT05234840: platelet rich plasma, Triamcinolone.

Is NCT05234840 still recruiting?

NCT05234840 is currently completed. Last updated 10 February 2022.

Last reviewed 2022-02-10 · How we verify

NCT05234840

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

"Platelet-Rich Plasma" Epidural Injection an Emerging Strategy in Lumbar Disc Herniation

Completed NA Last updated 10 February 2022

What this trial tests

NA trial testing platelet rich plasma in PRP in 30 participants. Completed in 30 June 2021.

Timeline

1 April 2019

Primary endpoint
1 May 2021

30 June 2021

Quick facts

Lead sponsor	Queen Savang Vadhana Memorial Hospital, Thailand
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	30
Start date	1 April 2019
Primary completion	1 May 2021
Estimated completion	30 June 2021
Sites	1 location across Thailand

Drugs / interventions tested

platelet rich plasma — full drug profile →
Triamcinolone (TRIAMCINOLONE) — full drug profile →

Conditions studied

PRP — all drugs for PRP →

Sponsor

Queen Savang Vadhana Memorial Hospital, Thailand

Who can join

Adults 20 to 55, any sex, with PRP. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate the efficacy of platelet-rich plasma (PRP; double-spin) in treatment of single-level lumbar herniated nucleus pulposus (HNP) in comparison to triamcinolone. RCT was conducted with 30 patients included.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

"Platelet-Rich Plasma" epidural injection an emerging strategy in lumbar disc herniation: a Randomized Controlled Trial.
Wongjarupong A, Pairuchvej S, Laohapornsvan P, Kotheeranurak V, et al · · 2023 · cited 23× · PMID 37118707 · DOI 10.1186/s12891-023-06429-3
A comprehensive review of cell transplantation and platelet-rich plasma therapy for the treatment of disc degeneration-related back and neck pain: A systematic evidence-based analysis.
Schol J, Tamagawa S, Volleman TNE, Ishijima M, et al · · 2024 · cited 15× · PMID 38919468 · DOI 10.1002/jsp2.1348

Verify or expand the search:

Other trials of platelet rich plasma

Trials testing the same drug.

NCT06319768 — Efficacy of Intralesional Injection of Pentoxifylline, Platelet-Rich Plasma, and Combined Pentoxifylline With Platelet-R · NA · unknown
NCT05795660 — The Effect of Platelet Rich Plasma for the Treatment of Osteochondral Lesions of the Talus · Phase 1 · not yet recruiting
NCT06249503 — Ultrasound Guided Activated and Non Activated Platelet Rich Plasma Injection Versus Hydro Dissection by Steroids. · Phase 4 · completed
NCT05603468 — Effect of PRP vs Corticosteroid in Rotator Cuff Tendinopathy Subtypes in Arthroscopic Repair · Phase 4 · active not recruiting
NCT05339542 — Platelet Rich Plasma in Plantar Fasciitis · NA · completed

Other recruiting trials for PRP

Currently open trials in the same condition.

NCT07470359 — Comparison of Functional Outcomes Following Arthroscopic ACL Reconstruction With Peroneus Longus Autograft With and With · Phase 2 · recruiting
NCT06472323 — The Efficacy and Safety of Pulsed Radiofrequency Combined With Platelet-rich Plasma for the Trigeminal Neuralgia · recruiting
NCT06028009 — PRP Injections for Genitourinary Syndrome of Menopause · NA · active not recruiting
NCT05412381 — PRP in ACLR to Prevent PTOA · Phase 3 · recruiting
NCT05279560 — Ovarian PRP (Platelet Rich Plasma) Injection for Follicular Activation · NA · active not recruiting

Other Queen Savang Vadhana Memorial Hospital, Thailand trials

Trials by the same sponsor.

NCT07260240 — Comparison of the Efficacy of Intravenous Fluid Administration Between Bolus and Continuous Infusion in Pregnant Women W · NA · recruiting
NCT07000214 — Peripheral Magnetic Stimulation With Balance Training to Decrease Fall Risks in Diabetic Polyneuropathy · Phase 2 · recruiting
NCT07395518 — A Randomized Controlled Trial Comparing the Incidence of Surgical Site Infections in Cesarean Section With and Without S · NA · enrolling by invitation
NCT06749314 — Comparison of Endoscopic Lumbar Decompression and Minimally Invasive Transforaminal Lumbar Interbody Fusion(MIS-TLIF) fo · NA · not yet recruiting
NCT07399834 — Comparison of Single Tunnel Versus Double Tunnel Techniques for Coracoclavicular Stabilization in Acromioclavicular Join · NA · enrolling by invitation

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05234840 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Queen Savang Vadhana Memorial Hospital, Thailand
Last refreshed: 10 February 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05234840.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing